Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration
Frontiers in Immunology2025cited by 4position: middledoi
Neoadjuvant immunochemotherapy improves clinical outcomes of patients with esophageal cancer by mediating anti-tumor immunity of CD8+ T (Tc1) and CD16+ NK cells
Frontiers in Immunology2024cited by 12position: middledoi